Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 26, 2021 13:06 ET | Source: Theratechnologies

Theratechnologies lauréate du prix innovation de l'ADRIQ 2021 dans la catégorie « sciences de la vie »

MONTRÉAL, 26 nov. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies ou la Société) (TSX : TH) (NASDAQ: THTX), une société biopharmaceutique axée sur le développement et la...
November 26, 2021 13:06 ET | Source: Theratechnologies

Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category

MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
November 03, 2021 07:30 ET | Source: Theratechnologies

Theratechnologies fera une présentation à la 30ème conférence annuelle de Crédit Suisse sur les soins de santé le 11 novembre 2021

MONTRÉAL, 03 nov. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ: THTX), une société biopharmaceutique axée sur le développement et la commercialisation...
November 03, 2021 07:30 ET | Source: Theratechnologies

Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021

MONTREAL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
October 26, 2021 02:00 ET | Source: Theratechnologies

Theratechnologies annonce un accord de remboursement en Italie pour Trogarzo® pour les patients admissibles présentant une infection par le VIH-1 multirésistante

MONTRÉAL, 26 oct. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ : THTX), société biopharmaceutique axée sur le développement et la commercialisation de...
October 26, 2021 02:00 ET | Source: Theratechnologies

Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1

MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
October 26, 2021 02:00 ET | Source: Theratechnologies

THERATECHNOLOGIES ANNUNCIA IN ITALIA UN ACCORDO PER LA RIMBORSABILITA’ DI TROGARZO® PER I PAZIENTI CON INFEZIONE DA VIRUS HIV-1 MULTIRESISTENTE

MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), azienda biofarmaceutica focalizzata sullo sviluppo e la commercializzazione di...
October 22, 2021 09:15 ET | Source: Theratechnologies

Theratechnologies annonce une publication dans la revue Frontiers in Oncology soulignant la plateforme SORT1+ Technology™ pour cibler le mimétisme vasculogénique médié par la SORT1

MONTRÉAL, 22 oct. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ : THTX), une compagnie biopharmaceutique se spécialisant dans la commercialisation et le...
October 22, 2021 09:15 ET | Source: Theratechnologies

Theratechnologies Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology™ for Targeting SORT1-Mediated Vasculogenic Mimicry

MONTREAL, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
October 13, 2021 07:00 ET | Source: Theratechnologies

Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update

- Q3 FY2021 consolidated sales grow 27% over Q3 FY2020 – - Ongoing Part A of Phase 1 program evaluating TH1902 for sortilin-expressing cancers indicating better tolerability than docetaxel alone – ...